Novel |
EFNA4 |
ephrin A4 |
- EPH-Ephrin signaling
- EPH-Ephrin signaling
- EPHA-mediated growth cone collapse
- EPHA-mediated growth cone collapse
- EPH-ephrin mediated repulsion of cells
- EPH-ephrin mediated repulsion of cells
|
|
|
Novel |
TGFBR1 |
transforming growth factor beta receptor 1 |
- Downregulation of TGF-beta receptor signaling
- Downregulation of TGF-beta receptor signaling
- TGF-beta receptor signaling activates SMADs
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- TGFBR2 Kinase Domain Mutants in Cancer
- TGFBR1 KD Mutants in Cancer
- TGFBR1 LBD Mutants in Cancer
- UCH proteinases
- Ub-specific processing proteases
- TGFBR3 regulates TGF-beta signaling
|
- 4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline
- Naphthyridine Inhibitor
- 3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole
- N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide
- 2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine
- N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine
- Fostamatinib
|
- Loeys-Dietz syndrome (LDS)
- Familial thoracic aortic aneurysm and dissection (TAAD); Aortic aneurysm familial thoracic type (AAT)
|
Novel |
TNC |
tenascin C |
- Integrin cell surface interactions
- Syndecan interactions
- ECM proteoglycans
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Post-translational protein phosphorylation
|
|
|
Novel |
ZEB1 |
zinc finger E-box binding homeobox 1 |
- Interleukin-4 and Interleukin-13 signaling
- Negative Regulation of CDH1 Gene Transcription
- Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition
|
|
- Fuchs corneal dystrophy (FECD); Fuchs endothelial corneal dystrophy
- Posterior polymorphous corneal dystrophy (PPCD)
|
Novel |
ZNF33A |
zinc finger protein 33A |
- Generic Transcription Pathway
- Regulation of endogenous retroelements by KRAB-ZFP proteins
- Regulation of endogenous retroelements by KRAB-ZFP proteins
|
|
|
|
ACAP1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
|
|
|
|
ACTN1 |
actinin alpha 1 |
- Platelet degranulation
- Syndecan interactions
- Nephrin family interactions
- Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
- RHOD GTPase cycle
- RHOBTB2 GTPase cycle
- RHOF GTPase cycle
|
|
|
|
ACTN4 |
actinin alpha 4 |
- Platelet degranulation
- Nephrin family interactions
|
|
- Nephrotic syndrome and focal segmental glomerulosclerosis
|
|
ARHGAP5 |
Rho GTPase activating protein 5 |
- RHOA GTPase cycle
- RHOB GTPase cycle
- RHOC GTPase cycle
- CDC42 GTPase cycle
- RAC1 GTPase cycle
- RHOD GTPase cycle
- RHOQ GTPase cycle
- RHOG GTPase cycle
- RHOJ GTPase cycle
- RAC3 GTPase cycle
- RHOF GTPase cycle
- RND3 GTPase cycle
- RND2 GTPase cycle
- RND1 GTPase cycle
|
|
|
|
CANX |
calnexin |
- Assembly of Viral Components at the Budding Site
- MHC class II antigen presentation
- Interleukin-35 Signalling
- Calnexin/calreticulin cycle
- Interleukin-27 signaling
- Maturation of spike protein
- Maturation of spike protein
- Regulation of CDH1 posttranslational processing and trafficking to plasma membrane
- Antigen Presentation: Folding, assembly and peptide loading of class I MHC
- Antigen Presentation: Folding, assembly and peptide loading of class I MHC
|
- Antihemophilic factor, human recombinant
- Tenecteplase
- Lanoteplase
- Calcium citrate
- Calcium Phosphate
- Lonoctocog alfa
- Moroctocog alfa
- Calcium phosphate dihydrate
|
|
|
CD151 |
CD151 molecule (Raph blood group) |
- Assembly of collagen fibrils and other multimeric structures
- Type I hemidesmosome assembly
|
|
- Nephropathy with pretibial epidermolysis bullosa and deafness
|
|
CD274 |
CD274 molecule |
- Co-inhibition by PD-1
- STAT3 nuclear events downstream of ALK signaling
- Regulation of PD-L1(CD274) translation
- GSK3B-mediated proteasomal degradation of PD-L1(CD274)
- SPOP-mediated proteasomal degradation of PD-L1(CD274)
- AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274)
- PD-L1(CD274) glycosylation and translocation to plasma membrane
|
- Sildenafil
- Valproic acid
- Nivolumab
- Pembrolizumab
- Atezolizumab
- Durvalumab
- Avelumab
- Camrelizumab
- Envafolimab
- Cosibelimab
- AUNP-12
- CA-170
- anti-OX40 antibody BMS 986178
|
|
|
CD36 |
CD36 molecule (CD36 blood group) |
- Platelet degranulation
- Cross-presentation of particulate exogenous antigens (phagosomes)
- ER-Phagosome pathway
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- Toll Like Receptor TLR6:TLR2 Cascade
- PPARA activates gene expression
- Scavenging by Class B Receptors
- Scavenging by Class B Receptors
- Transcriptional regulation of white adipocyte differentiation
- Intracellular metabolism of fatty acids regulates insulin secretion
- MyD88 deficiency (TLR2/4)
- IRAK4 deficiency (TLR2/4)
- Regulation of TLR by endogenous ligand
- Interleukin-4 and Interleukin-13 signaling
- Neutrophil degranulation
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
|
|
|
|
CD46 |
CD46 molecule |
- Regulation of Complement cascade
|
|
|
|
CD82 |
CD82 molecule |
|
|
|
|
CD9 |
CD9 molecule |
- Platelet degranulation
- Acrosome Reaction and Sperm:Oocyte Membrane Binding
- Uptake and function of diphtheria toxin
|
|
|
|
CD93 |
CD93 molecule |
|
|
|
|
COL18A1 |
collagen type XVIII alpha 1 chain |
- Collagen degradation
- Activation of Matrix Metalloproteinases
- Collagen biosynthesis and modifying enzymes
- Assembly of collagen fibrils and other multimeric structures
- Integrin cell surface interactions
- Laminin interactions
- Collagen chain trimerization
|
|
- Vitreoretinal degeneration, including: Stickler syndrome type I (STL1); Stickler syndrome type II (STL2); Snowflake vitreoretinal degeneration (SVD); Wagner syndrome 1 (WGN1); Knobloch syndrome (KNO); Enhanced S-cone syndrome (ESCS); Autosomal dominant vitreoretinochoroidopathy (ADVIRC)
- Polymicrogyria; Bilateral frontal polymicrogyria (BFP); Bilateral frontoparietal polymicrogyria (BFPP); Bilateral perisylvian polymicrogyria (BPP); Bilateral parasagittal parieto-occipital polymicrogyria (BPOP); Bilateral generalised polymicrogyria (BGP); Unilateral Polymicrogyria (ULP)
|
|
CRKL |
CRK like proto-oncogene, adaptor protein |
- Frs2-mediated activation
- Frs2-mediated activation
- Downstream signal transduction
- MET activates RAP1 and RAC1
- MET receptor recycling
- Erythropoietin activates RAS
- Erythropoietin activates RAS
- Regulation of signaling by CBL
|
|
|
|
DAG1 |
dystroglycan 1 |
- Non-integrin membrane-ECM interactions
- ECM proteoglycans
- ECM proteoglycans
- Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3
- Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2
- Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1
- DAG1 core M2 glycosylations
- DAG1 core M3 glycosylations
- DAG1 core M1 glycosylations
- Regulation of expression of SLITs and ROBOs
- EGR2 and SOX10-mediated initiation of Schwann cell myelination
- Formation of the dystrophin-glycoprotein complex (DGC)
- Formation of the dystrophin-glycoprotein complex (DGC)
- Matriglycan biosynthesis on DAG1
|
|
- Limb-girdle muscular dystrophy (LGMD)
|